Novartis Investigative Site

Havířov, Czech Republic 736 01

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Scelrosis

Studies at this site

• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. — Completed
• A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients — Completed